新入荷
再入荷
00100-1/asset/63b1bae9-e543-4e7c-8e6f-8d1d65b53b4d/main.assets/gr2a_lrg.jpg)
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial - The Lancet
4.8
（9件）
タイムセール
終了まで
00
00
00
999円以上お買上げで送料無料（※）
999円以上お買上げで代引き手数料無料
999円以上お買上げで代引き手数料無料
通販と店舗では販売価格や税表示が異なる場合がございます。また店頭ではすでに品切れの場合もございます。予めご了承ください。
商品詳細情報
| 管理番号 |
新品 ：8933142206
中古 ：8933142206-1 |
メーカー | 89ee88a7222 | 発売日 | 2025-03-17 16:05 | 定価 | 15000円 | ||
|---|---|---|---|---|---|---|---|---|---|
| カテゴリ | |||||||||
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial - The Lancet
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial - The Lancet,Choroidal Response to Intravitreal Bevacizumab Injections in Treatment-Naïve Macular Neovascularization Secondary to Chronic Central Serous Chorioretinopathy,VYXEOS® | Efficacy From Phase 3 Study,The use of pembrolizumab monotherapy for the management of head and neck squamous cell carcinoma (HNSCC) in the UK - Vasiliadou - 2024 - International Journal of Cancer - Wiley Online Library,Consistent administration of cetuximab is associated with favorable outcomes in recurrent/metastatic head and neck squamous cell carcinoma in an endemic carcinogen exposure area: a retrospective observational study [PeerJ],
健康・医学の作品リスト
レディースの製品
